Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Mease

Showing results (21-30 of 174) with videos related to

Pageof 18
Sort By:
The Journal of Rheumatology. Supplement|July 4, 2012
Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL)Arthur Kavanaugh, Philip Mease
Rheumatology and Therapy|October 18, 2016
Erratum to: Secukinumab: A New Treatment Option for Psoriatic ArthritisPhilip Mease, Iain B McInnes
Journal of the American Academy of Dermatology|January 1, 2005
Diagnosis and treatment of psoriatic arthritisPhilip Mease, Bernard S Goffe
Rheumatology and Therapy|October 18, 2016
Secukinumab: A New Treatment Option for Psoriatic ArthritisPhilip Mease, Iain B McInnes
Annals of the Rheumatic Diseases|July 17, 2012
The link between obesity and psoriatic arthritisJuan D Cañete, Philip Mease
The Journal of Investigative Dermatology|June 15, 2007
The first World Psoriasis and Psoriatic Arthritis ConferenceElizabeth Horn, Kenneth Gordon, Philip Mease
Seminars in Arthritis and Rheumatism|July 22, 2018
Functional impairment measurement in psoriatic arthritis: Importance and challengesPhilip Mease, Vibeke Strand, Dafna Gladman
Rheumatology (Oxford, England)|October 20, 2021
IL-23 and axial disease: do they come together?Philip Mease, Filip van den Bosch
Best Practice & Research. Clinical Rheumatology|December 25, 2022
Horizon scan: State-of-the-art therapeutics for psoriatic arthritisJoseph Hutton, Philip Mease, Deepak Jadon
The American Journal of Managed Care|July 1, 2010
Pregabalin: an alpha2-delta (alpha2-delta) ligand for the management of fibromyalgiaLesley Arnold, Philip Mease, Stuart Silverman
Pageof 18

Showing results (21-30 of 174) with videos related to

Sort By:
Pageof 18
The Journal of Rheumatology. Supplement|July 4, 2012
Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL)Arthur Kavanaugh, Philip Mease
Rheumatology and Therapy|October 18, 2016
Erratum to: Secukinumab: A New Treatment Option for Psoriatic ArthritisPhilip Mease, Iain B McInnes
Journal of the American Academy of Dermatology|January 1, 2005
Diagnosis and treatment of psoriatic arthritisPhilip Mease, Bernard S Goffe
Rheumatology and Therapy|October 18, 2016
Secukinumab: A New Treatment Option for Psoriatic ArthritisPhilip Mease, Iain B McInnes
Annals of the Rheumatic Diseases|July 17, 2012
The link between obesity and psoriatic arthritisJuan D Cañete, Philip Mease
The Journal of Investigative Dermatology|June 15, 2007
The first World Psoriasis and Psoriatic Arthritis ConferenceElizabeth Horn, Kenneth Gordon, Philip Mease
Seminars in Arthritis and Rheumatism|July 22, 2018
Functional impairment measurement in psoriatic arthritis: Importance and challengesPhilip Mease, Vibeke Strand, Dafna Gladman
Rheumatology (Oxford, England)|October 20, 2021
IL-23 and axial disease: do they come together?Philip Mease, Filip van den Bosch
Best Practice & Research. Clinical Rheumatology|December 25, 2022
Horizon scan: State-of-the-art therapeutics for psoriatic arthritisJoseph Hutton, Philip Mease, Deepak Jadon
The American Journal of Managed Care|July 1, 2010
Pregabalin: an alpha2-delta (alpha2-delta) ligand for the management of fibromyalgiaLesley Arnold, Philip Mease, Stuart Silverman
Pageof 18